Dapagliflozin, Spironolactone or Both for HFpEF

Condition:   Heart Failure With Preserved Ejection Fraction Interventions:   Drug: Dapagliflozin;   Drug: Spironolactone;   Drug: Spironolactone + Dapagliflozin Sponsors:   Universidade do Porto;   FMUP;   Centro Hospitalar Universitário de São João, E.P.E.;   Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials